13.76
price up icon0.44%   0.06
pre-market  시장 영업 전:  13.25   -0.51   -3.71%
loading

Syndax Pharmaceuticals Inc 주식(SNDX)의 최신 뉴스

pulisher
01:26 AM

Syndax: Q3 Earnings Snapshot - CT Insider

01:26 AM
pulisher
12:09 PM

Decoding Syndax Pharmaceuticals Inc (SNDX): A Strategic SWOT Insight - GuruFocus

12:09 PM
pulisher
Nov 03, 2025

Syndax Pharmaceuticals Reports Strong Q3 2025 Growth - TipRanks

Nov 03, 2025
pulisher
Nov 03, 2025

Syndax Pharmaceuticals (SNDX) Q3 2025 Earnings: Revenue Jumps 21% - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

Syndax targets $10B market as Revuforj gains NPM1 approval and Q3 revenue rises 21% - MSN

Nov 03, 2025
pulisher
Nov 03, 2025

Will Syndax Pharmaceuticals Inc. stock maintain momentum in 2025July 2025 Setups & Safe Swing Trade Setup Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Syndax Pharmaceuticals Q3 2025 Earnings Call Transcript - MarketBeat

Nov 03, 2025
pulisher
Nov 03, 2025

Transcript : Syndax Pharmaceuticals, Inc., Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

Syndax Pharmaceuticals (SNDX) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Nov 03, 2025
pulisher
Nov 03, 2025

Is Syndax Pharmaceuticals Inc. stock reversal real or fakeGap Down & Weekly High Potential Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Syndax Pharmaceuticals Q3 Earnings: EPS of -$0.70 Beats Estimate, Revenue of $45.9M Misses Estimate - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

Syndax Pharmaceuticals Grows Revenue As Wall Street Stays Bullish - Finimize

Nov 03, 2025
pulisher
Nov 03, 2025

Earnings Flash (SNDX) Syndax Pharmaceuticals, Inc. Reports Q3 Revenue $45.9M, vs. FactSet Est of $48.0M - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

Syndax Reports Third Quarter 2025 Financial Results and Provides Business Update - The Manila Times

Nov 03, 2025
pulisher
Nov 03, 2025

Syndax Pharmaceuticals falls as Q3 revenue misses estimates - Investing.com

Nov 03, 2025
pulisher
Nov 03, 2025

[10-Q] Syndax Pharmaceuticals Inc Quarterly Earnings Report | SNDX SEC FilingForm 10-Q - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

[8-K] Syndax Pharmaceuticals Inc Reports Material Event | SNDX SEC FilingForm 8-K - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

SNDX: Syndax Pharmaceuticals to Showcase Promising Data at ASH 2 - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

Is Syndax Pharmaceuticals Inc. stock poised for growth2025 Technical Overview & Low Volatility Stock Recommendations - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025 - The Manila Times

Nov 03, 2025
pulisher
Nov 03, 2025

Syndax Announces Compelling Revuforj® (revumenib) and - GlobeNewswire

Nov 03, 2025
pulisher
Nov 03, 2025

Syndax (NASDAQ: SNDX) to present Revuforj and Niktimvo data in 23 ASH 2025 abstracts - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

How Syndax Pharmaceuticals Inc. stock performs in rate cut cycles2025 Risk Factors & Safe Swing Trade Setup Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Using Ichimoku Cloud for Syndax Pharmaceuticals Inc. technicals2025 Big Picture & Entry and Exit Point Strategies - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Leading vs lagging indicators on Syndax Pharmaceuticals Inc. performanceJuly 2025 Short Interest & Entry Point Confirmation Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Syndax Pharmaceuticals Inc. (1T3) stock undervalued by metricsMarket Activity Recap & Weekly Momentum Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

AlphaQuest LLC Sells 18,370 Shares of Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat

Nov 03, 2025
pulisher
Nov 03, 2025

Applying Wyckoff theory to Syndax Pharmaceuticals Inc. stockBreakout Watch & Verified Technical Trade Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Detecting support and resistance levels for Syndax Pharmaceuticals Inc.Jobs Report & Verified Swing Trading Watchlist - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is it too late to sell Syndax Pharmaceuticals Inc.Weekly Trade Summary & Growth-Oriented Investment Plans - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

How Syndax Pharmaceuticals Inc. stock performs in stagflationJuly 2025 Chart Watch & Verified Momentum Watchlists - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Syndax Pharmaceuticals Q3 2025 Earnings Preview - MSN

Nov 02, 2025
pulisher
Nov 02, 2025

Is Syndax Pharmaceuticals Inc. showing signs of accumulationMarket Volume Summary & AI Driven Stock Movement Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Syndax Pharmaceuticals (SNDX) Q3 Earnings Preview: Key Expectati - GuruFocus

Nov 02, 2025
pulisher
Nov 02, 2025

Kura Oncology's Ziftomenib Poised For Differentiation (NASDAQ:KURA) - Seeking Alpha

Nov 02, 2025
pulisher
Nov 02, 2025

How risky is Syndax Pharmaceuticals Inc. stock nowJuly 2025 Recap & Free Technical Pattern Based Buy Signals - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Y Intercept Hong Kong Ltd Makes New Investment in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat

Nov 01, 2025
pulisher
Oct 31, 2025

B. Riley Issues Optimistic Estimate for SNDX Earnings - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Syndax Pharmaceuticals Inc (SNDX) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance

Oct 31, 2025
pulisher
Oct 31, 2025

Syndax Pharmaceuticals Inc (SNDX) Q3 2025 Earnings Report Previe - GuruFocus

Oct 31, 2025
pulisher
Oct 31, 2025

Syndax Pharmaceuticals Hits Day Low at $13.03 Amid Price Pressure - Markets Mojo

Oct 31, 2025
pulisher
Oct 31, 2025

Is Syndax Pharmaceuticals Inc. stock a safe investment in uncertain markets2025 Technical Patterns & Weekly Momentum Picks - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Syndax Pharmaceuticals’ Promising AML Study Update: Key Insights for Investors - TipRanks

Oct 31, 2025
pulisher
Oct 31, 2025

Is Syndax Pharmaceuticals Inc. (1T3) stock considered safe havenJuly 2025 Sentiment & Fast Moving Stock Watchlists - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Why Syndax Pharmaceuticals Inc. stock is rated strong buyJuly 2025 Selloffs & Weekly Momentum Picks - newser.com

Oct 31, 2025
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
자본화:     |  볼륨(24시간):